Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-021274
Filing Date
2023-05-11
Accepted
2023-05-11 16:18:19
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atha-20230331.htm   iXBRL 10-Q 2663397
2 EX-31.1 atha-ex31_1.htm EX-31.1 19395
3 EX-31.2 atha-ex31_2.htm EX-31.2 19234
4 EX-32.1 atha-ex32_1.htm EX-32.1 11388
5 EX-32.2 atha-ex32_2.htm EX-32.2 9769
6 GRAPHIC img105240929_0.jpg GRAPHIC 154086
  Complete submission text file 0000950170-23-021274.txt   9034937

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atha-20230331_lab.xml EX-101.LAB 410857
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atha-20230331_cal.xml EX-101.CAL 40652
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atha-20230331_pre.xml EX-101.PRE 290614
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atha-20230331.xsd EX-101.SCH 53022
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atha-20230331_def.xml EX-101.DEF 149476
60 EXTRACTED XBRL INSTANCE DOCUMENT atha-20230331_htm.xml XML 1610546
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Filer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39503 | Film No.: 23911319
SIC: 2836 Biological Products, (No Diagnostic Substances)